Successful Portfolios LLC Takes $211,000 Position in The Clorox Company (NYSE:CLX)

Successful Portfolios LLC purchased a new position in The Clorox Company (NYSE:CLX) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,293 shares of the company’s stock, valued at approximately $211,000.

A number of other institutional investors also recently bought and sold shares of CLX. Vanguard Group Inc. lifted its position in shares of Clorox by 0.3% during the first quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock worth $2,339,150,000 after purchasing an additional 48,632 shares during the last quarter. Nuance Investments LLC lifted its position in shares of Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares during the last quarter. Van ECK Associates Corp lifted its position in shares of Clorox by 1,715.5% during the second quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock worth $199,411,000 after purchasing an additional 1,380,724 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Clorox by 14.4% during the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company’s stock worth $131,200,000 after purchasing an additional 120,716 shares during the last quarter. Finally, Parsifal Capital Management LP purchased a new position in shares of Clorox during the fourth quarter valued at $128,245,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

Shares of Clorox stock traded up $1.63 on Friday, reaching $159.68. The company’s stock had a trading volume of 83,674 shares, compared to its average volume of 1,236,916. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09. The company has a market capitalization of $19.78 billion, a P/E ratio of 71.25, a PEG ratio of 3.19 and a beta of 0.41. The stock has a 50-day moving average price of $157.03 and a 200-day moving average price of $144.74.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Analysts expect that The Clorox Company will post 6.64 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.06%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s payout ratio is presently 217.86%.

Analyst Ratings Changes

Several equities analysts have recently commented on CLX shares. Deutsche Bank Aktiengesellschaft raised their price target on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. DA Davidson reiterated a “neutral” rating and issued a $153.00 target price on shares of Clorox in a research note on Friday, September 6th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and lifted their target price for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Barclays lifted their target price on Clorox from $130.00 to $137.00 and gave the company an “underweight” rating in a research note on Friday. Finally, Citigroup boosted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $148.33.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.51% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.